Alpha Tau Medical LtdNASDAQ:DRTS
- LAST PRICE2.3200
- TODAY'S CHANGE (%)0.0250 (1.0893%)
- Bid / Lots2.1600/ 5
- Ask / Lots2.3700/ 1
- Open / Previous Close2.3100 / 2.2950
- Day Range
- 52 Week Range
- Volume14,750
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DRTS |
|---|---|---|
| 10:36 ET | 1053 | 2.31 |
| 10:38 ET | 200 | 2.3 |
| 11:18 ET | 250 | 2.3 |
| 12:19 ET | 100 | 2.3091 |
| 12:28 ET | 192 | 2.305 |
| 01:09 ET | 2521 | 2.3 |
| 01:13 ET | 7350 | 2.305 |
| 02:34 ET | 300 | 2.3097 |
| 03:06 ET | 100 | 2.305 |
| 03:15 ET | 1181 | 2.305 |
| 04:00 ET | 789 | 2.32 |
Today
Nov 19, 2024
Press Release: Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update, from 4:00PM ET on Tuesday Nov 19, 2024 by Dow Jones
4:00PM ET on Tuesday Nov 19, 2024 by Dow JonesAlpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update, from 4:00PM ET on Tuesday Nov 19, 2024 by Dow Jones
4:00PM ET on Tuesday Nov 19, 2024 by Dow Jones
Nov 13, 2024
Alpha Tau to Participate in Citi's 2024 Global Healthcare Conference and Piper Sandler's 36th Annual Healthcare Conference, from 8:30AM ET on Wednesday Nov 13, 2024 by Dow Jones
8:30AM ET on Wednesday Nov 13, 2024 by Dow Jones
Oct 23, 2024
DJ Alpha Tau Medical Price Target Maintained With a $9.00/Share by HC Wainwright & Co., from 5:59AM ET on Wednesday Oct 23, 2024 by Dow Jones
5:59AM ET on Wednesday Oct 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Alpha Tau Medical Ltd | 160.5M | -5.9x | --- |
EUDA Health Holdings Ltd | 164.0M | -9.4x | --- |
Cibus Inc | 129.1M | -0.2x | --- |
Orchestra Biomed Holdings Inc | 205.8M | -3.6x | --- |
Heartbeam Inc | 75.5M | -4.0x | --- |
Atlantic International Corp | 253.2M | -0.9x | --- |
Company Information
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.
Contact Information
- Headquarters
- Kiryat Hamada 5JERUSALEM, Israel 9777605
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Uzi Sofer
- Chief Financial Officer
- Raphi Levy
- Chief Operations Officer
- Amnon Gat
- Chief Technology Officer
- Ronen Segal
- Chief Scientific Officer
- Yona Keisari
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $160.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 69.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.77 |
EPS | $-0.40 |
Book Value | $1.21 |
P/E Ratio | -5.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
